Physician profile
Anna Chan
NPI 1598008823
$334.00
in general payments reported to CMS, 2019-2025
8 companies · $29.32 in 2025
The $29.32 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $42.72 · 2021: $11.80 · 2022: $12.82 · 2025: $29.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $29.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $29.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $120.44 | 2019 | |
| Glaxosmithkline, LLC. | $80.14 | 2019-2020 | |
| Baxter Healthcare | $42.14 | 2022-2025 | |
| Phadia US INC. | $24.96 | 2019 | |
| Mylan Pharmaceuticals INC. | $20.73 | 2019 | |
| Meridian Bioscience INC. | $19.98 | 2019 | |
| Genentech USA, INC. | $13.81 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.80 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.